KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Co-Diagnostics (CODX) over the last 8 years, with Q3 2025 value amounting to -$38353.0.

  • Co-Diagnostics' Change in Inventory rose 6733.66% to -$38353.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$153487.0, marking a year-over-year increase of 5614.67%. This contributed to the annual value of -$265489.0 for FY2024, which is 3573.87% up from last year.
  • Co-Diagnostics' Change in Inventory amounted to -$38353.0 in Q3 2025, which was up 6733.66% from -$56663.0 recorded in Q2 2025.
  • Co-Diagnostics' 5-year Change in Inventory high stood at $3.1 million for Q1 2022, and its period low was -$2.1 million during Q2 2021.
  • Over the past 5 years, Co-Diagnostics' median Change in Inventory value was -$66211.0 (recorded in 2024), while the average stood at -$149075.4.
  • As far as peak fluctuations go, Co-Diagnostics' Change in Inventory surged by 27183.89% in 2022, and later plummeted by 79005.7% in 2023.
  • Co-Diagnostics' Change in Inventory (Quarter) stood at -$1.3 million in 2021, then skyrocketed by 101.32% to $16846.0 in 2022, then tumbled by 790.06% to -$116247.0 in 2023, then surged by 72.7% to -$31735.0 in 2024, then dropped by 20.85% to -$38353.0 in 2025.
  • Its last three reported values are -$38353.0 in Q3 2025, -$56663.0 for Q2 2025, and -$26736.0 during Q1 2025.